Crocus Technology
6.11.2018 14:01:05 CET | Globenewswire | Press release
The CT300 is a 2D magnetic sensor with an angular error well below 0.5°
SANTA CLARA, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Crocus Technology Inc., a leading supplier of disruptive Tunnel Magneto-Resistance (TMR) sensors, today announces the CT300 device, a new break-through TMR-based angular (2D) magnetic sensor with an extremely low angular error and high stability over a wide temperature and voltage ranges to address a variety of markets.
The CT300 is designed using Crocus’s revolutionary Magnetic Logic Unit™ (MLU™) technology and consists of two full-bridge magnetic resistor networks capable of two-dimensional sensing. In the presence of a rotating magnetic field, the CT300 senses the field and produces two sets of differential signals representing the sine (SIN) and cosine (COS) waveforms. Once the differential signals of the CT300 are processed and compensated, the resulting angular error will be at or below 0.5° over a temperature range of -40°C to +150°C. A single CT300 can measure the absolute angle resulting from a full 360° rotation and can sense magnetic fields ranging from 20 mT to 80 mT.
“The CT300 is a high-performance TMR angular position sensor that showcases the strength of our MLU technology. It will help our customers achieve both higher accuracy measurements and stable performance over the operating range of temperatures and fields for applications that require a precise angular position, rotation direction, and speed information,” states Zack Deiri, CSMO and GM of Sensor Products at Crocus Technology. “The CT300 exceeds the performance metrics of competing solutions in terms of angular error combined with very low noise, high frequency response, and low power consumption which makes the device ideal for, but not limited to, battery operated consumer hand-held devices and IoT applications.”
The CT300 addresses the demands of the consumer, industrial, medical and automotive markets and is highly suited for applications such as OIS (Optical Image Stabilization)/AF (Auto-Focus)-enabled camera modules, optical encoders, BLDC motor control, IoT enabled smart devices and appliances, automation equipment, industrial controls and robotics where precise angular position measurements are required.
CT300 is available in wafer/KGD (Known-Good-Die), an 8-lead TSSOP package, and in an ultra-low profile and small form factor 8-lead DFN package. Samples will be available in December 2018 and fully qualified for production in the first quarter (Q1) of 2019.
About Crocus Technology
Crocus Technology develops and supplies magnetic sensors and embedded memory solutions based on its patented TMR sensor technology, the Magnetic Logic Unit™ (MLU™). Crocus’s magnetic sensors bring significant advantages to industrial and consumer electronic applications requiring high sensitivity, stable temperature performance, low power and low cost. Crocus is headquartered in Santa Clara, California and has offices in Grenoble, France and Beijing and Shenzhen, China. For more information, please visit http://www.crocus-technology.com .
© 2018 Crocus Technology International Corp. All rights reserved. Crocus Technology, MLU, and combinations thereof are trademarks of Crocus Technology Inc. and Crocus Technology SA. Other names are for informational purposes only and may be trademarks of their respective owners
For more information, please contact:
Wayne Seto
Crocus Technology
Tel: +1-408-380-8316
Email: wseto@crocus-technology.com
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zymeworks Inc.15.6.2026 00:05:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Crinetics Pharmaceuticals, Inc.14.6.2026 22:30:00 CEST | Press release
Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
Crinetics Pharmaceuticals, Inc.14.6.2026 20:45:00 CEST | Press release
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
King Faisal Specialist Hospital & Research Centre14.6.2026 09:01:00 CEST | Press release
KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026
Genmab A/S13.6.2026 18:45:00 CEST | Press release
Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
